Format

Send to

Choose Destination
See comment in PubMed Commons below
Neuroreport. 2007 Jul 16;18(11):1181-5.

Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats.

Author information

1
Department of Physiology, Faculty of Medicine, Neuroscience Research Center of Shandong Province, Qingdao University, Qingdao, Shandong, PR China.

Abstract

The effects of myricetin on 6-hydroxydopamine (6-OHDA)-induced neurodegeneration in the substantia nigra-striatum system were investigated. By high-performance liquid chromatography electrochemical detection, we showed that the dopamine content in the striatum decreased after 6-OHDA treatment, which could be restored by myricetin. The immunohistochemistry and semiquantitative reverse transcription-PCR studies showed that myricetin could prevent the 6-OHDA-induced decrease of tyrosine hydroxylase positive neurons and the tyrosine hydroxylase mRNA expression in the substantia nigra. Perls' iron staining study further demonstrated that myricetin prevented the 6-OHDA-induced increase of iron-staining cells in the substantia nigra. These results suggested that the protective effects of myricetin on the toxicity of 6-OHDA could be attributed to the myricetin-suppressed iron toxicity.

PMID:
17589323
DOI:
10.1097/WNR.0b013e32821c51fe
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Wolters Kluwer
    Loading ...
    Support Center